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Abstract 
In this study we examined whether an early life intervention can permanently alter 
individual differences in emotional behavior, as modeled using bred high and low responder rats.  
We found that neonatal FGF2 administration permanently alters the emotional brain systems of 
individuals prone to anxious and inhibited behavior (bred low responders)  as well as those 
animals that do not show these vulnerabilities (bred high responders).  These neural changes 
increased positive ultrasonic vocalizations in response to experimenter induced play.  The brain 
and behavior altering changes that result from a single neonatal dose of FGF2 could be a 
powerful treatment for individuals vulnerable to depression and anxiety-like behavior. 
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Title: Effects of Neonatal FGF2 Administration on Vocalizations in Rats Susceptible to 
Anxiety and Depression 
Mood disorders and substance abuse result from the interactions between genetic 
susceptibility and environmental factors.  We can model this interaction in rats by measuring 
“novelty seeking” or “thrill seeking” type behavior which may represent a fundamental trait that 
predicts a wide range of emotional and psychosocial behaviors.  Rats show variable behaviors in 
response to a novel environment and can be selectively bred based on their exploratory 
locomotion into “thrill seekers” or high responders (HR) and “non-thrill seekers” or low 
responder (LR) groups (Piazza et al., 1989).  In this study we examined whether an early life 
intervention can permanently alter individual differences in emotional behavior, as modeled 
using bred high responders (bHR) & bred low responders (bLR) rats. 
Modeling individual differences in emotional reactivity using HR and LR Rats 
To model individual differences in the development of emotional disorders in the 
laboratory we use the HR-LR paradigm which has been shown to be predictive of a range of 
drug-related and emotional behaviors.  For instance, HR rats have greater rates of cocaine and 
amphetamine self-administration and have greater activity responses following exposure to the 
drugs (Piazza et al., 1989).  The HR-LR trait also correlates with spontaneous anxiety behaviors, 
stress-reactivity and other measures of emotionality.  HR rats show reduced levels of anxiety 
behavior in a number of behavioral assays including the light-dark box and elevated T-maze and 
also show greater wakefulness and reduced slow wave sleep.  In response to chronic mild 
intermittent stress, bLR developed signs of anhedonia, a symptom where experiencing pleasure 
is lost, sooner and to a greater degree than bHR, suggesting that bLR are more susceptible to 
depression (Stedenfeld et al., 2011). 
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HR rats also have many differences in gene expression in the brain, as well as 
neuroendocrine functions, in comparison to LR rats (Bouyer et al., 1998; Kabbaj et al., 2000).  
For example, HR rats exhibit an increased and prolonged corticosterone (CORT) secretion when 
exposed to a novel environment (Piazza et al., 1991).  The increased CORT secretion is thought 
to mediate behavioral functions though three modes of action.  First, CORT regulates and 
changes neuronal activity in the brain.  Second, CORT is essential to the management of 
homeostatic responses caused by environmental stimuli and stress.  Third, dopamine neurons, 
which are implicated in locomotor, emotional, and motivational behavior, have CORT receptors, 
also known as glucocorticoid receptors (GR), on their cell bodies and are therefore modulated by 
CORT (Piazza et al., 1991). The increased CORT secretion is thought to be mediated by HRs’ 
reduced levels of hippocampal glucocorticoid receptor (GR), which diminishes the GR-mediated 
negative feedback on CORT release (Figure 1). 
Hippocampal regulation of CORT and emotional behavior is significant because major 
depression is associated with atrophy of brain regions, including the hippocampus.  Furthermore, 
increased hippocampal GR has been implicated in anxiety-like behavior, as the blockade of GR 
receptors increased exploration and decreased anxiety-like behavior in the light-dark box for LR 
rats.  Gene expression differences have also been found for corticotrophin-releasing factor 
(CRF), with stimulates CORT secretion.  In HR rats, results showed greater basal CRF mRNA 
levels in the paraventricular nucleus and amygdala which are also important brain areas for the 
regulation emotional behavior (Kabbaj et al., 2000).  Others report HR-LR differences in 
dopamine transmission in the nucleus accumbens, norepinephrine and serotonin transmission in 
the hippocampus, and levels of neurogenesis in the hippocampus, which are all implicated in 
mediating emotional behavior (Jama et al., 2008; Lemaire et al., 1999).  
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Given this evidence regarding novelty seeking, drug self-administration, stress 
responsiveness, and spontaneous anxiety-like behavior, Stead et al. suggested that HR and LR 
rats not only respond differently to motivating stimuli, but in fact, demonstrate fundamental 
differences in emotional and environmental reactivity (2006).  Furthermore, differential c-fos 
activation, a marker of neuronal activity, in HR versus LR rats in response to psychological 
stress supports the claim that HRs and LRs have significant differences in emotions (Kabbaj and 
Akil, 2001).  Differences in neuronal activity in emotional circuits is also consistent with the 
view that “novelty seeking” or “thrill seeking,” the homologous behavior in humans, may 
represent a basic trait that predicts a range of emotional behaviors as seen in HR and LR rats 
(Stead et al., 2006; Zuckerman et al., 1979).   
Individual differences in the expression of FGF2 predict emotional behavior. 
 A major reported difference between bLR and bHR is in hippocampal fibroblast growth 
factor (FGF) system, which has been implicated in mood disorders (Turner et al., 2006).  
Members of the FGF family have previously been shown to be dysregulated in individuals with 
major depression (Evans et al., 2004).  According to past studies, the FGF family is known to 
have 22 ligands and five receptors in humans and is distributed throughout the brain. FGF1 and 
FGF2 are considered the prototypical ligands and are the most widely studied (Turner et al., 
2006).   
FGF2 causes proliferation of neural stem cells and differentiation into neuronal or glial 
cells at all stages of development and is found predominantly in the hippocampus but expressed 
in the cortex as well. (Gonzalez et al., 1995; Palmer et al., 1999; Turner et al., 2006).  In FGF2 
knockout mice (FGF2-/-), animals were found to have reduced amplification of neuroepithelial 
cells during  neurogenesis, which resulted in shunted neuronal density in the cerebral cortex and 
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alterations in cortical cytoarchitecture (Raballo et al., 2000).  Studies in neonatal FGF-/- mice 
showed that population size of hippocampal granule neurons were reduced but were reversed by 
FGF administration (Cheng et al., 2002).  FGF2 also plays an important role in promoting 
proliferation of hippocampal neuroprogenitor cells and is up-regulated after brain injury.  In 
FGF2-/- mice, the dentate gyrus, a region of the hippocampus, showed decreased neurogenesis in 
response to brain insult than control animals, which was subsequently reversed by FGF2 
administration (Yoshimura et al., 2001).  
It has been hypothesized that the FGF system plays a role in depression due to its effects 
on hippocampal neurogenesis and neuronal plasticity.  Since the hippocampus projects to the 
emotional regions of the brain, such as the prefrontal cortex, cingulate gyrus and the amygdala, it 
is thought that alterations in cell proliferation underlie some of the key stress-related and 
emotional changes seen in anxiety and depression (Manji and Dumam, 2001).  In rats, after acute 
stress, FGF2 is increased in limbic brain structures as well as the hippocampus (Molteni et al., 
2001).   In humans, FGF activity has been found to correlate with response to stress, 
antidepressant and antipsychotic medication, and major depression.  Evans et al. found that in 
patients with major depression, a decreased expression of the FGF family is found in limbic 
structures (2004).  Furthermore, this decrease is not apparent in patients treated with 
medications, such as SSRIs, which are shown to increase FGF2 receptors.  For these reasons, it is 
suggested that FGF2 has neuroprotective and neurotropic properties which might act as a 
homeostatic response to challenges, and that a brain with reduced FGF levels has a lesser ability 
to respond to brain insults and therefore a greater vulnerability to anxiety and depression (Turner 
et al., 2009).  Due to these important projections onto emotional brain regions from the 
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hippocampus and because FGF receptors are present in these output regions, it is hypothesized 
that this family of factors plays an important role in modulating depression (Turner et al., 2006).  
Studies exploring the HR/LR phenotypes show that bLR rats have significantly lower 
levels of hippocampal FGF2 mRNA relative to bHR (Perez et al., 2009).  The importance of 
FGF2 on drug-related behavior has been demonstrated in outbred rats which were administered 
FGF2 on PND2 and found to have enhanced propensity to self-administer cocaine (Turner et al., 
2009).  Interestingly, previous studies have shown that early life FGF2 injection decreases 
anxiety-like behavior (Turner et al., 2011).  This evidence is particularly powerful because it 
demonstrates that an early life FGF2 intervention can permanently alter individual differences in 
emotional behavior. 
Another potential area of impact for FGF2 is the periaqueductal gray, which has been 
implicated in influencing the emotional brain systems that mediate separation distress in animals 
and depression in humans (Panksepp and Watt, 2011).  The PAG is regulated by oxytocin and 
opioids.  Moreover, increased activity in this region, and potentially increases in FGF2, may 
potentiate negative affect (Panksepp and Watt, 2011).   
Measuring the effects of neonatal FGF2 treatment on emotional behaviors in bLR and 
bHR using ultrasonic vocalizations 
While many behavioral assays such as light-dark box and elevated T-maze provide 
information on anxiety-like behavior, a novel technique may provide better insight about the 
emotional states of rats following FGF2 treatment.  Rats make ‘trills,’ high frequency 
vocalizations (USVs) that have been associated with the different affective states that occur 
during anticipation of reward or punishment (Knutson et al., 2008).  Knutson et al. found that 
low frequency (22 kHz) calls typically indicate an anticipation of punishment or describe 
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avoidance behavior, whereas high frequency (50 kHz) calls indicate anticipation of a reward 
(2008).  Furthermore, 50 kHz calls can be classified into flat and frequency modulated (FM) 
categories (Figure 2).  More complex, FM calls have been associated with appetitive stimuli 
whereas simpler flat calls are observed more in social conditions that are not necessarily 
appetitive (Burgdorf et al., 2009).  In rats, USVs have been proposed as an index of affective 
state, for example, during sexual encounters or exposure to drugs of abuse  a greater number of 
FM calls are observed (Ahrens et al., 2008; Burgdorf, 2001).  
Researchers have previously studied USVs as a result of heterospecific hand play 
(“tickling”), which is thought to activate the dopamine reward system, inducing positive 
affective states (Brugdorf, 2001).  Heterospecific hand play mimics the rough-and-tumble play 
rats engage in when in social settings. This manipulation elicits 50 kHz USVs from rats, a 
measure of positive affect. Researchers have found individual differences in USV responses 
from rats, some chirping more often than others.  These differences correlated with the affective 
behavior of rats. Mallo reports that male rats that emitted less 50 kHz calls during tickling 
showed greater susceptibility to stressful stimuli and showed increased exploratory behavior 
(2008).  Therefore, USVs elicited by tickling may be a method for measuring individual 
differences and changes in emotional systems in response to FGF2 treatment in bLR and bHR 
rats.  
Our study explores the long term effects of FGF2 on the neural systems of neonatal rats 
by measuring the USVs that young rats produce when experiencing positive affective states 
during tickling.  We utilized heterospecific hand play with rats, which elicited positive affective 
states and 50 kHz calls, to study the differences in USVs between bLR and bHR rats who had 
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received either a single injection of FGF2 or vehicle the day after birth (PND2).  After four days 
of hand play the rats were sacrificed and brains collected.   
We predicted that there would be a strong, significant increase in the amount of flat and 
FM USVs produced by juvenile bLR rats while undergoing hand play following neonatal FGF2 
administration.  We expected that bLR rats would benefit the most from FGF2 treatment because 
of their lower levels of FGF2 expression and increased vulnerability to depression-like 
symptoms.  We expected a similar trend for bHR rats; however, since bHRs already expressed 
relatively high amounts of FGF2 and are relatively less susceptible to depression-like symptoms, 
the effects of FGF2 are expected to be less pronounced than in bLRs.  The overarching 
hypothesis of this study was that neonatal FGF2 administration would permanently alter the 
emotional response of individuals (bLRs) prone to anxiety and depression.  These alterations 
would result in increased positive responses to tickling (USVs).   
Methods 
Subjects 
High anxiety-like behavior (bLR) and low anxiety-like behavior (bHR) Sprague–Dawley 
rats were generated from our in-house breeding colony, where the bLR/bHR lines have been 
maintained for several generations (generation 32 and 33).  The rats were pair housed in standard 
transparent cages under a controlled light cycle (12 h light/12 h dark cycle) with lights on at 
06:00 h.  The rats were in controlled temperature and humidity settings with food and water 
available ad libitum.  The experiments followed the “Principles of Laboratory Animal Care” 
(http://www.nap.edu/readingroom/books/labrats/) and the “Guidelines for the Care and Use of 
Mammals in Neuroscience and Behavioral Research” (National Research Council 2003), and are 
approved by the University Committee on the Use and Care of Animals (Flagel et al., 2008).  
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Procedure 
On the day after birth (PND2), litters were culled into groups of six males and six 
females and injected with either FGF2 (20 ng/g in 50 μL 0.1 M PBS with 1% BSA s.c. into the 
axillary space; Sigma) or vehicle (0.1 M PBS with 1% BSA s.c.).  FGF2 is at near maximal 
levels 24 h later (Turner et al., 2011).  
The FGF treated bLR (13 rats) and bHR (10 rats) and control groups of bLR (11 rats) and 
bHR (10 rats) were given daily sessions of experimenter-induced tickling for 4 days preceded by 
one day of habituation on PND22.  During the habituation and tickling session an animal was 
taken to a nearby room with dim lighting conditions (~40 lux), removed from its home cage and 
placed in an empty cage located under an ultrasonic detector.  The habituation day included brief 
animal handling and a two minute period for animals to acclimate to the novel cage environment 
without experimenter stimulation.  On tickling days, the tickling was done in accordance with 
Burgdorf et al. (2001), with rapid playful stimulation including pinning of the animal and finger 
and hand movement similar to human tickling.  While the stimulation is assertive, most of the 
animals should not feel fear or threatened due to the touching.  The ultrasound detector (NCMX-
HD Neutrik) was set to a range of 0-250kHz so as to amplify the ultrasonic sounds made by the 
rat (Ultrasoundgate amplifier: 416H).  The tickling session each day consisted of 2 minutes of 
stimulation, which was separated into four 15 second tickle sessions.  Periods when the 
experimenter stimulated the animals were called: “TickleON” and periods when the animals 
were not being stimulated were called: “TickleOFF.”  The rats were then placed back into their 
home cages.  During the hand play procedure, video was recorded and analyzed via IC Capture.   
After four days of hand play the rats were sacrificed on PND27 (24 hours after the last 
tickle session) and brains removed.  A separate set of brains were used to process FGF2 mRNA 
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expression in adulthood to determine whether there were long-term effects on FGF2 expression, 
as previously described in Turner et al. (2008).  
Data acquisition 
The 50 kHz range chirps were automatically measured and discriminated from foreign 
noises and 22kHz calls (Avisoft).  22kHz calls were visually counted by the experimenter, as the 
analysis software was set to filter out calls less than 25kHz due to the heavier amounts of noise 
in the lower frequency range.  Hand scoring was visualized using a spectrogram such that sounds 
10
-77
db and above were visible.  Hand scored 22kHz USV calls were defined by visually 
matching calls to the 22kHz calls shown in Figure 2.  Calls classified as 22kHz were a minimum 
duration of 100ms and flat in the spectral range of 22kHz to 36kHz.  This range includes calls up 
to 36kHz because some 22kHz flat calls were preceded by a short “ramp” component that had a 
higher frequency. 
During the automated scoring, the Avisoft software was set to distinguish the ideal sound 
element separation for our calls and we found that the “automatic whistle tracking” setting best 
selected the animals’ calls.  It uses an algorithm that searches for relatively stable peak frequency 
courses without dramatic frequency modulations.  For a sound to be counted as a USV, its 
maximum change in peak frequency per millisecond was set to ± 10kHz, the minimum call 
duration to 8msec and minimum time passed in between each call to 25msec.  These settings led 
to a less than 5% false detection rate when compared to hand-scored files for the total USV 
counts.  In order to further distinguish 50kHz calls from 22kHz and noise, we constructed a 
database that included a profile of all the calls made in the experiment and created a minimum 
peak frequency threshold of 36kHz.  This threshold was chosen because comparisons with hand 
scoring indicated that this threshold reliably eliminated 22kHz calls and some residual noise.  
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Inspection of a peak frequency histogram for the entire database similarly indicated that 36 kHz 
divided low frequency and high frequency clusters (Figure 3).  
 To differentiate 50kHz FM calls from flat calls, we demonstrated that there was a 
bimodal distribution for the mean standard deviation of the peak frequency (Figure 4).  We used 
this bimodal distribution to create a threshold cut-off at the 0.10 standard deviation (SD) mark 
(SD>0.10 = frequency modulated (FM), SD<0.10= flat).  A comparison with hand scoring 
indicated that this threshold predicted FM calls with 95% accuracy.  Flat calls were predicted 
with 75% accuracy because some multi-component FM calls only had one component detected 
and were artificially labeled as flat.  Calls were considered flat if they matched characteristics of 
“flat” and “short” calls as seen in Figure 2 and all other calls were considered FM calls, except 
for the 22kHz USV which were hand scored. 
FGF2 mRNA in situ hybridization 
A separate set of brains (PND60) were used for FGF2 gene expression (bLRVEH = 8; 
bLRFGF2 = 7; bHRVEH = 8; bHRFGF2 = 8).  Brains were then sliced at 10µm slices on a 
cryostat and stored at -80°C.  The in situ hybridization for this experiment was previously 
performed by Drs. Cortney Turner and Sarah Clinton, according to methodology described in 
Turner et al. (2008).  In general, in situ hybridization histochemistry technology measures 
mRNA expression inside the cells.  To do this, a radioactive riboprobe (“antisense”), 
complementary to the mRNA in the tissue, is placed on tissue sections and hybridizes with the 
transcript of interest, FGF2.  The amount and location of radioactivity (
35
S molecules conjugated 
to ribonucleotides) that hybridizes with the local mRNA can then be measured via 
autoradiography, which is a manner of visualizing radioactivity using x-ray film (Carter et al., 
2010).  For our in situ hybridization analysis, the sequence of rat mRNA used for generating the 
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probes was complementary to the following RefSeq database numbers: FGF2 (NM_019305 and 
716–994).  The exposure time for the film for our PAG tissue was 8 weeks.  Digitized 
autoradiographic images were quantified using NIH ImageJ software in the ventral and dorsal 
regions of PAG in tissue where the background used was the forceps major corpus callosum 
(Bregma: -7.64mm to -4.88; Paxinos and Watson, 1986).  Template figures were used to outline 
the region of the dorsal and ventral PAG. Signal was labeled if it surpassed 3.5X the standard 
deviation above the mean signal for the background elements from the corpus callosum.  Optical 
density was signal in the labeled area subtracted from the background signal (Figure 5).  Four to 
eight samples were measured for each brain. 
Data Analysis 
The number of flat and FM calls on habituation and tickling days was initially analyzed 
using four separate 2 x 2 (group x treatment) between subjects ANOVAs.  Then a more detailed 
ANOVA was performed of tickling days data that included the within-subjects variables of 
tickling day (day 1-4), tickleON/OFF periods and call type (flat vs. FM), as well as the between 
subjects variables of group and treatment.  Nonparametric analysis (Fisher’s exact test) was used 
for the 22kHz calls because so few animals made these calls during tickling sessions.  FGF2 
integrated density in the PAG was analyzed using a 2 x 2 between subjects ANOVA.  
Results 
Ultrasonic Vocalizations  
During the habituation period, bHR rats showed a significantly greater number of flat and 
FM calls in comparison to bLR rats.  Additionally, rats treated with FGF2 showed a significantly 
greater number of flat and FM calls in comparison to controls (Figure 6; Figure 7).  Thus, there 
was a main effect of phenotype and treatment on both the number of flat and FM calls during 
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habituation (phenotype on flat calls: F(1,40)=13.042, p = .01; phenotype on FM calls: 
F(1,40)=12.063, p = .01, treatment on flat calls: F(1,40)=5.713, p = .02, treatment on FM calls: 
F(1,40)=11.299, p > .01).  Our results also show bHR/bLR differences in the effect of FGF2 on 
flat and FM calls.  bHR rats showed a greater increase in flat and FM calls when treated with 
FGF2 in comparison to bLR rats during habituation.  Thus, during the habituation period our 
results also demonstrated an interaction between the effects of phenotype and FGF2 treatment on 
the number of flat and FM calls (F(1,40)=5.713, p = .02; F(1,40)=7.263, p = .01, respectively).  
During all the tickling days combined, similar results were found.  bHR rats showed a 
greater number of flat and FM calls in comparison to bLR rats and animals treated with FGF2 
showed a significantly greater number of flat calls in comparison to controls (Figure 8; Figure 9).  
There was a main effect of phenotype on both the number of flat and FM calls and a main effect 
of treatment on flat calls during tickling periods (phenotype on flat calls: F(1,40)=18.536, p < 
.01; phenotype on FM calls: F(1,40)=15.612, p < .01; treatment on flat calls: F(1,40)=5.919, p 
= .02).  Our results also showed bHR/bLR differences on FM calls.  bLR rats showed greater 
increases in FM calls when treated with FGF2 in comparison to bHR rats during tickling.  Thus, 
our results demonstrate an interaction between the effects of phenotype and FGF2 treatment on 
the number of FM calls during tickling (F(1,40)=5.218, p = .03).  
A more detailed analysis of USV calls across tickling days and while comparing 
tickleON and tickleOFF periods also showed interesting results.  The total numbers of USV calls 
changed across tickling days especially for the bHR-FGF2 group.  The bHR-FGF2 group showed 
an increase in calls with a peak on the final tickle day (Figure 10).  Thus, there was a main effect 
of day on the total number of USV calls, an interaction between day and group on total number 
of USV calls and an interaction between day, group and treatment on total number of USV calls 
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(F(2.538, 40)=4.491, p = .01; F(2.538, 40)=5.427, p > .01; F(2.538, 40)=8.930, p < .01, 
respectively).  A similar trend is observed when examining tickleON and tickleOFF sessions.  In 
general, animals showed a greater number of calls during tickleON periods in comparison to 
tickleOFF, and bHR-FGF2 rats showed a greater number of flat and FM vocalizations during 
tickleON and tickleOFF periods as tickling days progressed, while the other groups did not show 
significant changes (Figure 11; Figure 12).  There was a main effect of tickleON vs. tickleOFF 
on the total number of USV calls and an interaction between tickleON vs. tickleOFF and group 
(F(1, 40)=332.9, p < .01; F(1,40)=20.550, p < .01, respectively).   
Figures 11 and 12 also show notable differences in the distribution of flat and FM calls.  
In general, animals showed a greater number of flat calls than FM calls, while bHR rats and 
FGF2 rats show an increased proportion of FM calls to flat calls in comparison to bLR and 
control rats.  Interestingly, as tickling days continued the bHR-FGF2 rats, in particular, showed a 
marked increase in the proportion of FM calls to flat calls. There is a main effect of call type on 
total USV calls as well as an interaction between call type and group and treatment, respectively, 
on total USV calls (call type on total USV calls: F(1, 40)=313.142, p < .01; interaction between 
call type and group on USV calls: F(1, 40)=10.046, p > .01; interaction between call type and 
treatment on USV calls F(1, 40)=5.172, p = .03).  There was also an interaction between day, 
FM and flat calls, group, and treatment on total USV calls (F(2.740, 109.589)=91.594, p < .01).  
Figure 13 shows the proportion of animals that made 22kHz USV calls during recording.  
Significant differences between phenotype or treatment were not observed most likely due to the 
small numbers of 22kHz calls emitted overall (p = 1.0; p = .14, respectively). 
FGF2 In Situ Hybridization   
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Figure 14 and 15 shows results for FGF2 mRNA expression in the dorsal and ventral 
periaqueductal grey (PAG), respectively.  There were not any significant differences in the 
expression of FGF2 in any area of the PAG between the two phenotypes or two treatment groups 
(phenotype on average optical density (AOD) in the ventral PAG: F(1,27)=1.339, p = .26; 
phenotype on AOD in the dorsal PAG: F(1,27)=1.135, p = .30; treatment on AOD in the ventral 
PAG: F(1,27)=0.038, p = .85; treatment on AOD in the dorsal PAG: F(1,27)=0.013, p = .91; 
interaction of phenotype and treatment on AOD in the ventral PAG: F(1,27)=1.884, p = .18; 
interaction of phenotype and treatment  on AOD in the dorsal PAG: F(1,27)=0.002, p = .96). 
Discussion 
Our hypothesis that neonatal FGF2 administration permanently alters the emotional 
response of individuals (bLRs) prone to anxiety-like and depression-like behavior was supported 
by the results of our study.  Moreover, early life treatment with FGF2 increased positive affect in 
response to hand play, as measured by 50 kHz USVs.  Thus, a single early life intervention can 
permanently alter emotional response in vulnerable animals. 
 While we did not find significant changes in the expression of FGF2 mRNA in the 
ventral or dorsal PAG, many other areas of the brain may have been permanently altered, such as 
the hippocampus, as was previously shown in Turner et al. (2011).  Another interesting result 
was that FGF2-bHR rats showed a potentiation in 50kHz USV production as tickling days 
progressed, suggesting a possible sensitization to the rewarding environment.  This is similar to 
results found in other papers where bHR animals showed greater sensitization to drugs of abuse 
over time (García-Fuster et al., 2009).  Interestingly, drugs of abuse also impact brain regions 
that play a role in USV production, depression, and anxiety behavior (Cryan and Holmes, 2005).  
FGF2 Effects on Vocalizations     17 
This finding is profound in that it is also one of the few times that our lab has seen bHR animals 
respond to FGF2.   
While USV data from the tickling days showed significant differences between groups, 
the habituation day might give insight to an interesting phenomenon.  The habituation day 
showed significantly greater USVs among bHR in comparison to bLR, whereas tickling days did 
not show as pronounced of a difference in USVs between bHR and bLR.  This raises the 
question as to whether a ceiling effect in the number of USVs an animal can make is being 
observed for the bHRs on tickling days.  Since such a high number of USVs were already being 
made, it is possible that the rats cannot physically make any more USVs in 2 minute session by 
bHRs and that the number of USVs reached a plateau due to these motor limits. 
Alternatively, our results could be interpreted as FGF2 altering the brain regions involved 
in locomotor behavior, and, therefore USVs were increased as a by-product of increased motor 
movement.  Some researchers suggest that USVs are simply increased as breathing increases or 
when thoracic compression is induced in rats.  This theory would be supported by the fact that 
HR rats have greater locomotion and USV calls (Blumberg, 1992; Stead et al., 2006).   Perhaps 
the mechanisms of tickling are not fully understood, but our results unequivocally reveal a 
correlation between USVs with FGF2 treatment.  We still feel our original interpretation is still 
valid, because while USVs are influenced by locomotor behavior, USVs are still very tightly 
correlated to changes in the neurobiology of emotional brains systems (Ahrens et al., 2009; Mu 
et al., 2010).  Furthermore, our results show changes in the ratio of flat calls to FM calls 
suggesting that USVs are indeed a useful assay for measuring emotional behavior changes in 
rats.  With these principles, we feel that we can reach our conclusions based on a foundation of 
research. 
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One weakness of this study is the nature of the tickling experience.  Since it is the 
individual experimenter who is engaged in the tickling, every tickling experience cannot be 
replicated exactly, especially when taking into account the amount of touches and flips the 
experimenter completes.  Tickling is also influenced by the behavior of the rat.  If the animals 
show signs of distress, the experimenter is less able to make tickling contact than if the animal is 
excited and engaging.  Consequently, a possible mechanism of FGF2 effects on USV production 
could be that FGF2 altered how animals solicited tickling, which then changed the amount and 
quality of tickling induced, causing a change in USV count and type.  To fully address the 
mechanism of FGF 2 treatment, another area of follow-up investigation includes analysis of 
behavior video recorded during tickling experimentation to match exact tickleON and tickleOFF 
timings to USV sonograms, as well as the analysis of other behaviors, such as orienting or 
freezing movements.  Our follow up work includes analyzing film of the tickling session videos 
to determine if FGF2 animals solicit tickling more than controls.  Potentially, in the future, we 
could address these weaknesses by designing a study that does not use tickling to elicit USVs. 
For instance, measuring USVs during rewarding situations such as cocaine self-administration 
could give us similar insight.  However other rewarding situations could result in lesser overall 
USV calls, especially in adults which would give us less robust data (Kelly and Flagel, 
unpublished data).  Another weakness of our study includes the automated analysis of USV data.  
While only 75% of flat calls were accurately identified, FM calls still saw the same trend in 
changes betweens groups, which were identified at 95% accuracy.  In the future, using hand 
counting or further developing our technology to be able to perform more in depth analysis of 
call type would give us even more accurate and robust data.  
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These results raise several questions.  For instance, understanding how and where FGF2 
acts on the brain to determine behavior in animals is important.  One possible mechanism of 
FGF2 is effects on call production that permanently alter the brain at a young age and this causes 
changes in adult social behavior.  Another possible theory is that FGF2 alters neonatal 
interactions with the mother, which, in turn, alters their social behavior and social brain regions 
which propagate altered adult social behavior, including anxiety-like behavior (Cortney et al., 
2011).  Further localizing where FGF2 acts on the brain following injection on PND1, and what 
other behaviors it potentially impacts during early development, such as pups’ interactions with 
mothers, should be studied in the future.  Other brain regions besides the PAG that could be 
examined during the juvenile period or early development include the nucleus accumbens and 
the amygdala.  Moreover, gaining a better general understanding the significance of USVs 
elicited from tickling is important. 
Researchers now have a novel tool to assess for neurobiological differences in bLRs and 
bHRs.  Furthermore, the long term implications of a single early life intervention altering 
emotional brain systems, vulnerability to depression, and addictive behavior, are enormous.  The 
brain and behavioral changes that result from a single neonatal dose of FGF2 could be a 
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Figure Captions 
Figure 1.  Stress Axis. The figure illustrates the regulatory mechanisms of key emotional areas 
of the brain, including the hippocampus.  In the hypothalamus, the paraventricular nucleus 
releases CRF, which is transported to the anterior pituitary, where it causes the release of ACTH 
into the blood stream.  ACTH stimulates the adrenal cortex to synthesize and release the CORT. 
Glucocorticoids feed back at the level of the hippocampus, hypothalamus and pituitary to 
dampen excess activation of the stress axis (adapted from Hyman, 2009).  
Figure 2.  Representative calls for each of the categories of 50-kHz USVs (a) and a 22-kHz USV 
(b).  Several exemplar FM calls are shown for each 50-kHz call category and one exemplar flat 
call is shown; these examples are not necessarily consecutive nor made by the same rat.  The 
time scale for all 50-kHz calls is indicated in the top left panel (adapted from Wright et al., 
2010).  
Figure 3.  Distribution of the mean peak frequencies of USV calls.  This histogram indicates the 
overall frequency of occurrences for the mean peak frequencies for all USV calls.  The x-axis 
indicates the mean peak frequencies and the y-axis indicates the number of occurrences for each 
mean peak frequency.  The red line indicates the cut-off frequency at 36kHz used to separate 
50kHz calls from non calls. 
Figure 4.  Distribution of the standard deviations for the peak frequencies of USV calls.  This 
histogram indicates the overall frequency of occurrences for the standard deviations of the peak 
frequencies for all USV calls.  The x-axis indicates standard deviation of peak frequencies and 
the y-axis indicates the number of occurrences for each standard deviation.  The red line 
indicates the threshold cut-off used to separate flat calls from FM calls at 0.1 standard deviations.  
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Figure 5.  Sample autoradiographs and the templates used for the dorsal and ventral PAG.  This 
figure presents autoradiographs illustrating FGF2 labeled coronal brain slices.  Yellow lines 
indicate the templates used to outline (a) the dorsal and (b) ventral PAG for in-situ hybridization 
analysis.  
Figure 6.  bHRs and FGF2 treated groups showed greater 50kHz flat USV than controls on the 
habituation day.  This graph indicates significant differences in the number of 50kHz mean flat 
USV calls between the phenotypes and treatment groups as well as an interaction between  
phenotype and treatment (p < .05).  The x-axis indicates the treatment (FGF2 or vehicle) and the 
y-axis indicates the groups’ mean USV count, the phenotype groups are indicated in the key and 
the standard error of the mean is indicated on the figure with error bars (±SEM).  
Figure 7.  bHRs and FGF2 treated groups showed greater 50kHz FM USV than controls on the 
habituation day.  This graph indicates significant differences in the number of 50kHz mean FM 
USV between the phenotypes and treatment groups as well as an interaction between  phenotype 
and treatment (p < .05).  The x-axis indicates the treatment (FGF2 or vehicle) and the y-axis 
indicates the groups’ mean USV count, the phenotype groups are indicated in the key and the 
standard error of the mean is indicated on the figure with error bars (±SEM).  
Figure 8.  bHRs and FGF2 treated groups showed greater 50kHz flat USV than controls on the 
tickling days.  This graph indicates significant differences in the number of 50kHz mean flat 
USV calls between the phenotypes and treatment groups (p < .05).  The x-axis indicates the 
treatment (FGF2 or vehicle) and the y-axis indicates the groups’ mean USV count, the phenotype 
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groups are indicated in the key and the standard error of the mean is indicated on the figure with 
error bars (±SEM).  
Figure 9.  bHRs and FGF2 treated groups showed greater 50kHz FM USV than controls on the 
tickling days.  This graph indicates significant differences in the number of 50kHz mean FM 
USV calls between the phenotypes as well as an interaction between phenotype and treatment (p 
< .05).  The x-axis indicates the treatment (FGF2 or vehicle) and the y-axis indicates the groups’ 
mean USV count, the phenotype groups are indicated in the key and the standard of the mean is 
indicated on the figure with error bars (±SEM).  
Figure 10.  The mean number of 50 kHz USV increases across tickling days for the bHR-FGF2 
group.  This graph indicates overall differences in USV calls between bHR and bLR rats (p < 
.05).  T he x-axis indicates the day of tickling, the y-axis indicates the groups’ mean USV count, 
the groups are indicated in the key and the standard error of the mean is indicated on the figure 
with error bars (±SEM).   
Figure 11.  FGF2 rats showed increased USV FM call counts across days during TickleON 
sessions in comparison to USV flat calls.  This graph indicates overall changes in USV calls 
between bHR and bLR rats (p < .05).  The x-axis indicates the day of the TickleON session, the 
primary y-axis indicates the mean flat USV count and the secondary y-axis indicates the mean 
FM USV count; the standard error of the mean is indicated on the figure with error bars (±SEM). 
Figure 12.  bHR-FGF2 rats showed increased USV FM call counts across days during 
TickleOFF sessions in comparison to USV flat calls.  This graph indicates overall changes in 
USV calls between bHR and bLR rats (p < .05).  The x-axis indicates the day of the TickleOFF 
session, the primary y-axis indicates the mean flat USV count and the secondary y-axis indicates 
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the mean FM USV count; the standard error of the mean is indicated on the figure with error bars 
(±SEM). 
Figure 13.  No differences in proportion of 22kHz USV calls are observed between groups (p > 
.05).  The x-axis indicates the group and the y-axis indicates the proportion of animals per group 
that made 22kHz USV. 
Figure 14. There was no difference in FGF2 mRNA expression in the dorsal PAG (p > .05).  The 
x-axis indicates the treatment group and the y-axis indicates average optical density; for FGF2 
the standard error of the mean is indicated on the figure with error bars (±SEM). 
Figure 15. There was no difference in FGF2 mRNA expression in the ventral PAG (p > .05).  
The x-axis indicates the treatment group and the y-axis indicates average optical density for 
FGF2; the standard error of the mean is indicated on the figure with error bars (±SEM). 
 













FGF2 Effects on Vocalizations     30 















FGF2 Effects on Vocalizations     32 









FGF2 Effects on Vocalizations     33 
Figure 5.   
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Figure 15. 
 
 
